79 results
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
22 Jul 13
Other Events
12:00am
is to develop Liposomal Grb-2 as a targeted therapy against TNBC and IBC. Treatment goals are two-pronged: the first being to develop Liposomal Grb-2 … to treat and control or eliminate cancer metastasis in TNBC and IBC patients. Both of these treatment goals address high need situations for patients
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
7 Dec 12
Other Events
12:00am
TNBC and IBC. Treatment goals are two-pronged: the first being to develop Liposomal Grb-2 as a tumor reduction agent in combination with other approved … and IBC patients. Both of these treatment goals address high need situations for patients.
The developmental plan will be comprised of preclinical
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
4 Apr 13
Bio-Path Holdings Reports Fiscal Year 2012
12:00am
mortality rates. Bio-Path’s plan is to develop Liposomal Grb-2 as a targeted therapy against TNBC and IBC. Treatment goals are two-pronged: the first being … Liposomal Grb-2 as a drug to treat and control or eliminate cancer metastasis in TNBC and IBC patients. Both of these treatment goals address high
8-K
EX-99.2
BPTH
Bio-Path Holdings Inc
3 Apr 12
Bio-Path Holdings Reports Fiscal Year 2011
12:00am
professionals to achieve our goals.”
About Bio-Path’s Delivery Technology
Bio-Path’s drug delivery technology involves microscopic-sized liposome
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
15 May 24
Bio-Path Holdings Reports First Quarter 2024 Financial Results
7:10am
Exhibit 99.1
Bio-Path Holdings Reports First Quarter 2024 Financial Results
Marks Progress Across Key Clinical and Corporate Goals
Strengthened
8-K
EX-10.1
g2z134tz9ow9krxn9b81
27 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
15p1oe q2i30eonbmy5e
18 Aug 14
Bio-Path Holdings Reports Second Quarter 2014
12:00am
8-K
EX-10.5
ikt69azwsavhsu
20 Dec 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.5
rr6k7wh5qywc
27 Dec 17
Departure of Directors or Certain Officers
12:00am
S-8
EX-4.1
cbnz703 upi6jh
10 Dec 08
Registration of securities for employees
12:00am
8-K
EX-10.3
ipkf794irkh31hiy1mqc
19 Feb 08
Completion of Acquisition or Disposition of Assets
12:00am
424B5
x33yo
17 Jan 14
Prospectus supplement for primary offering
12:00am
424B5
6m70ps1jqw c8w89
21 Jan 14
Prospectus supplement for primary offering
12:00am
DEFR14A
0sgn5
23 Sep 10
Revised proxy
12:00am